BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 11356916)

  • 1. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
    Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition.
    Mukai E; Ishida H; Fujimoto S; Kajikawa M; Okamoto Y; Fujita J; Hamamoto Y; Tsuura Y; Yamada Y; Furukawa N; Ohta T; Seino Y
    Br J Pharmacol; 2000 Mar; 129(5):901-8. PubMed ID: 10696088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound.
    Furukawa N; Ohta T; Noguchi T; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Apr; 371(1):51-8. PubMed ID: 10355594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
    J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ATP-sensitive K+ channel by a non-sulfonylurea compound KAD-1229 in a pancreatic beta-cell line, MIN 6 cell.
    Mogami H; Shibata H; Nobusawa R; Ohnota H; Satou F; Miyazaki J; Kojima I
    Eur J Pharmacol; 1994 Nov; 269(3):293-8. PubMed ID: 7895769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between membrane potential and cytosolic Ca2+ concentration in beta cells from Sur1-/- mice.
    Haspel D; Krippeit-Drews P; Aguilar-Bryan L; Bryan J; Drews G; Düfer M
    Diabetologia; 2005 May; 48(5):913-21. PubMed ID: 15830184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells.
    Nenquin M; Szollosi A; Aguilar-Bryan L; Bryan J; Henquin JC
    J Biol Chem; 2004 Jul; 279(31):32316-24. PubMed ID: 15175349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide.
    Masuda K; Okamoto Y; Tsuura Y; Kato S; Miura T; Tsuda K; Horikoshi H; Ishida H; Seino Y
    Diabetologia; 1995 Jan; 38(1):24-30. PubMed ID: 7744225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine.
    Tsukuda K; Sakurada M; Niki I; Oka Y; Kikuchi M
    Horm Metab Res; 1998 Jan; 30(1):42-9. PubMed ID: 9503038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
    Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
    Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets.
    Maedler K; Størling J; Sturis J; Zuellig RA; Spinas GA; Arkhammar PO; Mandrup-Poulsen T; Donath MY
    Diabetes; 2004 Jul; 53(7):1706-13. PubMed ID: 15220194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor.
    Nadal A; Rovira JM; Laribi O; Leon-quinto T; Andreu E; Ripoll C; Soria B
    FASEB J; 1998 Oct; 12(13):1341-8. PubMed ID: 9761777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
    Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
    Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
    Hashiguchi S; Yada T; Arima T
    J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
    Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine.
    Doliba NM; Qin W; Vatamaniuk MZ; Li C; Zelent D; Najafi H; Buettger CW; Collins HW; Carr RD; Magnuson MA; Matschinsky FM
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E834-43. PubMed ID: 14736703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Ca(2+) modulation of ATP-sensitive K(+) channel activity in acetylcholine-induced activation of rat pancreatic beta-cells.
    Nakano K; Suga S; Takeo T; Ogawa Y; Suda T; Kanno T; Wakui M
    Endocrinology; 2002 Feb; 143(2):569-76. PubMed ID: 11796512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel D-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2+ in rat pancreatic beta-cells by stimulating Ca2+ influx.
    Fujitani S; Yada T
    Endocrinology; 1994 Mar; 134(3):1395-400. PubMed ID: 8119179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic and extrapancreatic sulfonylurea receptors.
    Panten U; Schwanstecher M; Schwanstecher C
    Horm Metab Res; 1992 Dec; 24(12):549-54. PubMed ID: 1478610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.